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Abstract
Background: Radiofrequency catheter ablation of excitation foci inside pulmonary veins (PV)
generates stenoses that can become quite severe during or after the follow-up period. Since severe
PV stenoses have most often disastrous consequences, it would be important to know the
underlying mechanism of this temporal evolution. The present study proposes a potential
explanation based on mechanical considerations.
Methods: we have used a mathematical-physical model to examine the cyclic increase in axial wall
stress induced in the proximal (= upstream), non-stenosed segment of a stenosed pulmonary vein
during the forward flow phases. In a representative example, the value of this increase at peak flow
was calculated for diameter stenoses (DS) ranging from 1 to 99%.
Results: The increase becomes appreciable at a DS of roughly 30% and rise then strongly with
further increasing DS value. At high DS values (e.g. > 90%) the increase is approximately twice the
value of the axial stress present in the PV during the zero-flow phase.
Conclusion: Since abnormal wall stresses are known to induce damages and abnormal biological
processes (e.g., endothelium tears, elastic membrane fragmentations, matrix secretion,
myofibroblast generation, etc) in the vessel wall, it seems plausible that the supplementary axial
stress experienced cyclically by the stenotic and the proximal segments of the PV is responsible for
the often observed progressive reduction of the vessel lumen after healing of the ablation injury. In
the light of this model, the only potentially effective therapy in these cases would be to reduce the
DS as strongly as possible. This implies most probably stenting or surgery.
Introduction
Radiofrequency (RF) catheter ablation of excitation foci in
extraparenchymal pulmonary veins (PV), or electrical iso-
lation of these veins from the left atrium, is increasingly
applied to suppress atrial fibrillation (AF). However, sev-
eral studies have shown that these techniques sometimes
create severe stenoses or even total occlusions in the con-
cerned veins [1-14]. Fig. 1 shows such a stenosis; further
illustrations can be found for instance in ref. [2] or on the
Web. The stenosis rates reported in the literature vary from
0 percents to more than 40% [6-9,15-18]. These discrep-
ancies are considerable but have actually simple causes: a)
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The definition of "stenosis" is not the same in all studies
(e.g. > 25, 30, 50, or even 70% diameter reduction) [16-
18]. b) The stenosis rate is sometimes defined per patient
instead of per treated PV [6,17]. c) The severity of the cre-
ated stenoses depends on many parameters, such as
number of ablated foci, extent of the treated intraluminal
zone, number and duration of the ablation pulses, tem-
perature and temperature distribution generated by the
RF-field in the vessel wall, etc. d) Stenoses without clinical
repercussions remain undiscovered if specific examina-
tions (CT, MRI, or echocardiography) are not performed.
e) Many stenoses are misdiagnosed even when the clinical
symptoms are evident [10,17,19]. f) Stenoses are underre-
ported [19]. Arentz et al. for instance found that the rate
of PV stenosis (defined as > 50% diameter reduction) is
considerably higher than the rate suggested by clinical
assessments [7]. In their study, only 3 patients out of 47
had symptoms suggestive of PV stenosis, whereas system-
atic surveillance by transoesophageal Doppler-echo and/
or magnetic resonance imaging revealed PV stenosis or
complete occlusion in 13 patients (28%).
The presence of an important PV stenosis at follow-up is
always a serious complication because of the progressive
repercussions these stenoses can have on pulmonary cir-
culation. It is indeed well known in corrective cardiovas-
cular surgery that the evolution of patients presenting
congenital PV stenoses is practically never favorable, due
(mainly) to the progression of stenosis severity with the
years [20,21]. This probably also applies to some stenoses
created by RF ablation. Several authors have indeed
reported a progression of PV stenoses during follow-up
[4,6-9,12-14]. For instance, Taylor et al. measured PV
stenoses angiographically in dogs at intervals of 2 to 4
weeks, 6 to 8 weeks, or 10 to 14 weeks, and observed an
increase of stenosis severity with time [4]. Similarly,
Arentz et al. performed angiographic and MRI measure-
ments in humans 2 years after a RF ablation procedure
Images of a right superior pulmonary vein stenosis (Reproduced with permission from ref. [14]) Figure 1
Images of a right superior pulmonary vein stenosis (Reproduced with permission from ref. [14]): (a) Angiographic view of the 
high grade stenosis (arrow). (b) Balloon dilatation (arrow). (c) Result after dilatation and stenting. (d) Pre-interventional com-
puted tomographic scanning of the stenosis (arrow), including infiltration in the dependent lung lobe (arrow). (e) Three-dimen-
sional magnetic resonance reconstruction of the stenosis (arrow). (f) Lung scan showing perfusion deficit in the right upper 
field (arrow).Journal of Cardiothoracic Surgery 2008, 3:24 http://www.cardiothoracicsurgery.org/content/3/1/24
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and came to the same conclusion [7]. Some moderate
stenoses may, however, also be smaller at follow-up than
shortly after the procedure. This is of course not surprising
because the inflammatory processes induced by the ther-
mal injury in the vessel wall [8] will ultimately vanish.
Nevertheless, it is obvious that the creation of PV stenoses
by the radio frequency ablation process is an important
issue, even if the true rate is not exactly known, and even
if this latter were of only a few percents.
Today, the risk of creating a severe PV stenosis is still non
negligible despite the methodological progresses accom-
plished in the late four years. It is therefore important to
find out why PV stenoses usually do not regress, and why
many will even progress. The phenomenon responsible
for the apparition of a stenosis during or shortly after the
intervention has been elucidated and does not seem to
play a role in the late evolution of PV stenoses [10,15,22].
The late evolution has also been studied, but only from a
phenomenological point of view [4]. We could not find
any potential explanation of the cause of this evolution,
despite an extensive literature search.
A well-known effect a severe stenosis has on the affected
vessel is, of course, the cyclic (and sometimes also
chronic) pressure rise that is generated in the vascular net
upstream of the stenosis. This pressure increase induces
media and intima thickening (among else), and may ulti-
mately lead to pulmonary insufficiency. Wall thickening
can be attributed to the changes in circumferential wall
stress induced by the cyclic or chronic increase of the
intravascular pressure but these stress changes cannot well
explain why stenoses do not regress or even progress.
Moreover, PV stenoses are not likely to induce high cir-
cumferential stresses in the upstream vessels because the
increase in capacitance of the pulmonary venous net dur-
ing systole (which is roughly equal to the stroke volume)
is due to a deformation of the lumens from a slit form into
a circular one, and not to a circumferential elongation of
the vein walls [23]. In contrast thereto, a cyclic increase of
axial wall stress in the vein segment situated upstream of
the stenosis, generated by this stenosis during the (for-
ward) flow phases, might play a still unsuspected role. In
this contribution, we propose a potential explanation for
the progression of PV stenoses that based on this effect of
stenoses on axial wall stress. Thereby, the main aspect is
not the mathematical-physical model we used but the
conclusions it leads to.
Methods
The model
We consider a stenosis on a PV. For simplicity, this steno-
sis is assumed to be at the vein ostium (Fig. 2). The basic
idea is that stenoses pull at the proximal (undiseased) ves-
sel segment during the (forward) venous flow phases,
increasing thus the axial wall stress in this vessel segment
cyclically beyond its "normal" value. In the following, this
"normal" stress is considered to be constant throughout
the cardiac cycle, and to have roughly the value it had in
the undiseased vein. Thus, the supplementary axial stress
generated cyclically by the stenosis adds to the "normal"
stress. "Peak flow" will denote peak venous flow through
the corresponding lung lobe.
We want to estimate the increase in axial wall stress at the
stenosis entrance (cross section x = 0 in Fig. 2) at peak
flow, and to compare this increase to "normal" axial
stress. Thereto, we have to calculate the pressure drop (∆P)
across the stenosis at peak flow, and the resulting axial
force F in the wall cross section x = 0. Division of this force
F by the cross sectional area of the wall yields then the
supplementary axial stress generated by the stenosis. We
consider the situation at peak flow because F is approxi-
mately maximal at that time, due to the fact that the pres-
sure drop across the stenosis is maximal at that time.
The pressure drop ∆P can be calculated using formulae
proposed by Back et al. [24] (See Appendix). One has to
know thereto the inner vessel diameter (Di, see Fig. 2), the
minimum inner diameter (Ds) (or, alternatively, the
degree of stenosis DS), the respective lengths of constric-
tion cone (Lc) and stenosis throat (Lm), the blood density
(ρ), the blood viscosity (η), and the peak flow (Q).
Since flow Q depends on the pressure available to drive
the blood through the considered lung lobe and the sten-
osis, on the hemodynamical resistance R of this lobe at
Schematic illustration of the considered pulmonary vein sten- osis Figure 2
Schematic illustration of the considered pulmonary vein sten-
osis. Since the dominant parameter from a hemodynamical-
mechanical point of view is the lumen reduction, this drawing 
is also valid for stenoses with a different morphology.
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peak (venous) flow, and on the resistance opposed by the
stenosis, the value of Q cannot be chosen freely, except for
DS = 0%. We make therefore use of the facts that the pat-
tern of flow in the large extraparenchymal PV is pulsatile,
and that the pulsatility is dominated by the changes in left
atrial pressure that take place throughout the cardiac
cycle. These facts were demonstrated by Rajagopalan et al.
[23] who also pointed out that all venous flow curves
recorded in their experiments resembled inverted left
atrial pressure curves. Based on these observations, we can
approximate the relationship between pressures and peak
flow in the considered lung lobe by the two equations:
PPA - PLA = Qo Ro and PPA- PLA = Q R + ∆P(Q).
PPA is the value of pulmonary arterial pressure at the time
of minimal left atrial pressure PLA. Based on the several
pressure curves displayed in publications of the same
authors [23,25,26], we take the pressure PPA equal to the
mean pulmonary artery pressure. The difference PPA - PLA
is thus the driving pressure at the time of peak flow. Qo is
the peak flow one would have at that time in absence of
the stenosis (DS = 0%), and Ro is the hemodynamical
resistance of the considered lung lobe for this flow (and at
that time). Q is the actual peak flow when the stenosis is
present (DS > 0%); it depends, of course, on the corre-
sponding hemodynamical resistance R of the considered
lobe. According to Rajagopalan et al. [25,26], all involved
pulmonary arteries, arterioles, capillaries, venules, and
veins have a more or less circular cross section at peak
flow. At that time, pulmonary resistance is therefore min-
imal. Since pulmonary veins do not have appreciable
vasoconstriction capabilities, and since they are also rela-
tively inextensible [27], we can assume for simplicity that
R has the same value for all DS that will be considered
(1% to 99% diameter reduction). We set thus R = Ro for all
DS values. The last term of the second equation, the pres-
sure drop ∆P(Q), is a function of flow Q, as already men-
tioned.
These equations, together with the formulas of Back et al.
[24], lead to a quadratic equation that allows to calculate
flow Q for any given DS value (Equation 8 in the Appen-
dix). The freely choosable parameters are: the pressures
PPA and PLA, peak flow Qo, the blood density and viscosity,
and the stenosis geometry. The corresponding value of
force F is then calculated using the corresponding pressure
drop ∆P(Q), the pressure PLA, and the formulae of Back et
al. The calculation is rather complex and is described in
detail in [28].
Since there is no evidence that stenoses induce a perma-
nent axial elongation of the affected PV, there is no reason
to assume that axial stress in the wall cross section x = 0
decreases below the "normal" value during flow diastole.
Consequently, one can consider that axial wall stress is
simply the sum of "normal" axial stress and supplemen-
tary axial stress, as assumed above.
Finally, we can also calculate the ratio "increased axial
wall stress over normal axial wall stress" at the entrance of
the stenosis. Contrary to absolute stress values, this ratio
does not depend on the actual area value of the wall cross
section.
Numerical example
In this section, we consider for illustration a representa-
tive PV, and we use the model described in the preceding
section to calculate the cyclic increase in axial wall stress
that can be expected at the entrance of the stenosis for DS
values ranging from 1% and 99%.
Based on the literature we chose for the parameters
needed for the calculation of the pressure drop ∆P a nor-
mal inner diameter (Di) of 10 mm at the stenosis entrance
[7,8,14,27,29] and a maximal flow velocity (over the
lumen) of 60 cm/s at peak flow Qo  (DS = 0%)
[5,14,15,18,30,31]. Assuming that the velocity profile at
peak flow is parabolic in absence of a stenosis, the value
of Qo is then 23.6 ml/s.
As already explained in the preceding section, we also
assume that the resistance R (= Ro) of the considered lung
lobe is independent of the DS, and that it is equal, at peak
flow, to the product "mean pulmonary artery pressure
(PPA) minus minimal left atrial pressure (PLA)" times
"flow Qo". With PPA = 20 mmHg and PLA = 0 mmHg (see
[[32], p. 1700]), we have thus R = (PPA - PLA)/Qo = 20
mmHg/23.6 ml/s. Introduction of this value into equa-
tion 8 allows to calculate then peak flow Q through the
considered lung lobe in dependence of the DS value (1%
to 99%).
For the calculation of the axial wall force F associated to a
particular DS value, we use the value of peak flow Q cal-
culated for this DS value, and we determine the corre-
sponding pressure drop ∆P(Q) across the stenosis. We add
then  ∆P(Q) to the minimal left atrial pressure PLA (0
mmHg) to obtain the pressure at the stenosis entrance at
peak flow Q. The value of F is then obtained as described
in [28].
In order to calculate the increase in axial wall stress gener-
ated by the force F, we have to chose a value for the rela-
tive wall thickness σ of the vein at the stenosis entrance (σ
= Do/Di, where Do and Di are the outer and inner diame-
ters of the intact vein segment, see Fig. 2). Based on vari-
ous publications, we choose an absolute wall thickness of
0.2 mm [26,33,34]. Together with Di = 10 mm, this yields
then a relative wall thickness of 1.04. Division of the F val-Journal of Cardiothoracic Surgery 2008, 3:24 http://www.cardiothoracicsurgery.org/content/3/1/24
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ues obtained for the particular DS values (1% to 99%)
yields then the values of the supplementary axial wall
stress in function of the actual DS.
To compare the increase in axial stress to the "normal"
axial stress that was present in the vein wall before the
apparition of the stenosis (and which is still the axial wall
stress of the non stenotic vein segment during the zero
flow phase), we need this "normal" stress value. Since val-
ues for PV are not available in the literature, we make the
(reasonable) assumption that "normal" axial stress has
the value one would obtain by inflating in vitro an
excised, occluded segment of the vein with a pressure
equal to the mean in vivo intravascular pressure. In the
present example, this pressure is practically equal to the
mean pressure of the left atrium (PLA, mean). With a value
PLA, mean of 8 mmHg [[32], p. 114], "normal" axial wall
stress is then 13 kPa.
Results
Fig. 3 shows the pressure falls in the considered lung lobe
and across the stenosis as functions of the parameter DS.
The sum of the two pressure drops is constant, as imposed
by the model. At high DS values, the pressure in the prox-
imal (= upstream) segment adjacent to the stenosis is
much greater than at low DS values. With regard to cir-
cumferential stress, this is probably not dramatic since the
pressure in this segment climbs anyway to about 13
mmHg during atrial systole after suppression of the atrial
fibrillation (Systolic left atrial pressure ranges from 6 to 20
mmHg, see [[32], p. 114]).
Fig. 4 shows the value of peak flow Q (curve falling from
the left to the right) and the ratio "axial stress at peak flow
at x = 0" over "normal axial stress" (curve rising from the
left to the right) for stenoses ranging from 1% to 99%
diameter reduction. Flow Q decreases continuously from
DS = 0% to DS = 100%, where it reaches (of course) zero.
This means that the mean pressure in the arterial and
venous nets upstream of the stenosis increases with sten-
osis severity. Furthermore, due to the progressive blood
congestion inside the affected lung lobe, the peak pres-
sures in the arteriolar, alveolar, and venous nets increase
abnormally, too, so that these vessels are likely to get
more and more damaged.
The second curve shows that the stress increase begins at
roughly 30% diameter reduction and reaches twice the
value of "normal" stress at high DS values. At these DS val-
ues, peak axial wall stress is thus three times greater than
normal axial stress. For a vessel that normally does not
have to bear such loads, this is certainly enormous and
must therefore have deleterious consequences.
The curves depicted in Fig. 3 and 4 depend, of course,
somewhat on the chosen parameter values. Nevertheless,
since the values used in this numerical example are repre-
Pressure drops in the considered lung lobe (curve falling  from the left to the right) and across the stenosis (curve ris- ing from the left to the right) in function of increasing degree  of diameter stenosis (DS) Figure 3
Pressure drops in the considered lung lobe (curve falling 
from the left to the right) and across the stenosis (curve ris-
ing from the left to the right) in function of increasing degree 
of diameter stenosis (DS). The sum of the two pressure 
drops (horizontal line) is constant, as imposed by the model.
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sentative for PVs, the results are also representative of the
magnitude of axial stress increases that can be generated
by a stenosis located on an extraparenchymal PV.
Discussion
The concepts and examples presented in this article show
that already a moderate stenosis (diameter reduction of
roughly 40%) located on the extraparenchymal part of a
PV can generate an appreciable increase in axial wall stress
in the proximal adjacent segment during peak forward
flow. It must be pointed out that this result has been
obtained using quite realistic data found in several publi-
cations. Since extraparenchymal veins are not firmly con-
nected to the surrounding tissues, the axial force F that
generates the cyclic stress increase cannot be absorbed by
these tissues and is therefore present not only at the sten-
osis entrance but also in the whole extraparenchymal vein
segment upstream of the stenosis. This segment is thus
submitted to the same cyclic tractions.
In the calculated example, the driving pressure (PPA - PLA)
was chosen equal to the value it would have in absence of
a stenosis. Therefore, one can state that axial stress in the
proximal segment begins to rise long before peak circum-
ferential stress starts increasing. The fact that media and
intima thickening is regularly found in intraparenchymal
veins in case of severe PV stenosis [35] suggests that, ulti-
mately, also mean circumferential stress becomes exces-
sive in all veins of the considered lung lobe.
The supplementary axial wall stress generated by the sten-
osis appears to be comparable to, or even much greater
than, "normal" axial stress. It is therefore quite likely to
have deleterious effects on the vessel wall. Abnormal bio-
logical processes induced by excessive wall stresses are,
indeed, increasingly reported in the literature [35-37],
although mainly for arteries and the circumferential direc-
tion. With regard to increases in axial stress, one can imag-
ine that these increases result for instance in
circumferential endothelium tears, elastic membrane dis-
ruptions, smooth muscle cell hyperplasia, matrix changes,
myofibroblast proliferation, etc.
The fact that venous pressures are lower than arterial pres-
sures does not allow, of course, to conclude that increases
in circumferential stress induced in extraparenchymal PV
by pressure rises can never be excessive. But in patients
treated by RF ablation, mean and peak pulmonary venous
pressures are not abnormally high at the end of the proce-
dure, and also not in the following days or weeks. Thus,
circumferential stress should not be excessive during this
period. One might, however, also argue that, before the
intervention, the pressure in the proximal vein segment
was very low over the whole cardiac cycle, due to the pres-
ence of the AF, and that the wall of the PV was, conse-
quently, abnormally thin. The strong increase of systolic
pressure in the proximal segment after restoration of the
normal atrial function might thus immediately damage
the PV via excessive circumferential stress. But, even if cir-
cumferential stress would strongly increase, this would
not explain why stenoses appear usually in the extraparen-
chymal segment of the PV and not in intraparenchymal
veins. It is thus unlikely that the progression of stenoses
observed in patients is due to excessive circumferential
stress. In contrast thereto, the concept of excessive axial
wall stress proposed in this contribution provides a poten-
tial explanation for these well established facts, and it
explains moreover why "non significant" stenoses (e.g. <
50% diameter reduction) are less prone to grow than
severe ones, as was observed by several authors [14,18].
If the proposed explanation of the evolution of stenoses
created by RF ablation should prove to be correct, then the
best way to avoid the potential consequences of stenoses
would be, of course, to find a method which does not cre-
ate stenoses, or only small ones. This may perhaps be the
case to a certain extent if lower ablation temperature can
be used, or for particular techniques like cryoablation and
ultrasound ablation [7,15,22]. Whether these techniques
produce PV stenoses or not is not yet clear [38,40].
If better methods cannot be found, angioplasty without or
with stent implantation will probably be unavoidable. For
instance, Saad et al. already recommend PV stenosis dila-
tation for patients with luminal narrowing of more than
70%, irrespective of the presence or absence of symptoms
[13]. The rationale of this recommendation resides in the
unknown likelihood of developing pulmonary hyperten-
sion, as well as in the risk of lesion progression to total
occlusion that could preclude the intervention
[8,11,12,14]. However, in the late 5 years many authors
have reported more or less negative results for angioplasty
with or without stenting after RF catheter ablation or sur-
gical repair of a pulmonary anomaly [10,19,41,42]. As far
as the successful cases are concerned, it was pointed out
that care was taken in the surgical or stenting procedure to
achieve a minimal residual stenosis [42,43]. This is in full
agreement with our results, which predict essentially that
small or moderate stenoses are less prone to worsen than
more severe ones.
If conventional stenting should remain unsatisfactorily
because of an elevated rate of in-stent restenosis [44,45],
the next step will probably be to try drug-eluting stents. It
is still unknown whether they can prevent in-stent resten-
osis as well as they do this in coronary arteries. But the rec-
ommendation of achieving the smallest possible residual
stenosis holds, of course, also for these stents because any
residual lumen obstruction acts as a stenosis with regard
to axial wall stress in the upstream vein segment. This rec-Journal of Cardiothoracic Surgery 2008, 3:24 http://www.cardiothoracicsurgery.org/content/3/1/24
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ommendation is straight forwardly supported by recent
results of Berkowitsch et al. who found that the relative
reduction in PV diameter one day after the RF ablation
was the strongest predictor of development of a severe PV
stenosis [46]. Noteworthy is, furthermore, that our model
is also in agreement with the observation that in patients
presenting a stenosis approaching 70% of the lumen (=
90% reduction of the diameter), the flow to the affected
lung is severely decreased [13]. As can be seen in Fig. 4,
flow appears to have decreased by roughly 50% at DS =
70%, and by more than 90% at DS = 90%.
In the purely surgical domain, it is now well acknowl-
edged that the sutureless marsupialization technique for
the treatment of stenosed PV yields better result than the
conventional technique [47-49]. According to our con-
cept, this is probably due to the fact that the sutureless
technique produces no post-operative stenosis, or a
smaller one than a conventional anastomosis.
With regard to the vein segment (if any) situated down-
stream of the stenosis, it seems conceivable that the same
mechanical phenomenon occurs in inverted direction
during the retrograde flow phase (which is restored by the
suppression of the AF). In this case, an important stenosis
would actually have a deleterious effect not only on the
upstream wall tissues but also on the downstream ones.
A further step would be now to test in vivo (for instance
in dogs) the "predictions" derived from the theoretical
model about the temporal evolution of PV stenoses in
function of the "initial" DS. This could be done for
instance by creating stenoses with a cuff placed around the
PV.
Conclusion
The concept of excessive axial stress proposed in this paper
as an explanation for the negative time evolution of PV
stenosis appears to be consistent with many well known
facts about PV stenoses. It predicts that the higher the
degree of stenosis after ablation, the greater the risk of an
unfavorable evolution will be. This is in full agreement
with the fact that severe PV stenoses seldom regress and
even tend to evolve toward complete occlusion. With
regard to angioplasty with or without stenting, it means
that achieving the smallest possible residual stenosis is
probably very important. Ideal would be, of course, to
have an ablation technique that does not create PV sten-
oses.
Authors' contributions
PAD and PAD adapted the general mathematical/physical
model to the particular case of pulmonray vein stenosis.
DCS provided the medical context of the article. All
authors read and approved the final manuscript.
Appendix
A) Calculation of the pressure drop across the stenosis
According to Back et al. [24] the pressure drop ∆P across a
stenosis can be expressed as
∆P = ∆Pef + ∆PeM + ∆Pmf
where ∆Pef and ∆PeM are pressure losses due to viscous and
inertial forces, respectively, in the constriction cone, and
∆Pmf the pressure loss due to viscous forces in the throat
(Poiseuille law).
The formula for ∆Pef is:
where:
The factor η is the viscosity of blood (3.5 mPa s), Lc the
length of the constriction cone (see Fig. 2), Di the inner
diameter of the vein at the cross section x = 0, Ds the inner
diameter in the throat of the stenosis, and Q the flow.
The formula for ∆PeM is:
∆PeM = 0.5 β ρ[(1/As)2 - (1/Ai)2] Q2,( 3 )
where β is a factor we set equal to 1 (as proposed by Back
et al. [24]). ρ is the density of blood, and Ai and As are the
luminal areas at the stenosis entrance and in the throat,
respectively.
The formula for ∆Pmf is:
where Lm is the length of the throat (see Fig. 2).
Writing the coefficients of Q and Q2 in ∆Pef, ∆PeM, and
∆Pmf in form of functions f1, f2, and f3 yields:
∆P = f1 Q + f2 Q2 + f3 Q = (f1 + f3) Q + f2 Q2 (5)
B) Calculation of flow Q
We express the relationship between pressures and hemo-
dynamical resistances in the considered lung lobe by:
PPA - PLA = R Q + ∆P = R Q + ∆Pef + ∆PeM + ∆Pmf
(6)
∆P
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where PPA is the pressure in the pulmonary artery at the
time of peak pulmonary flow through the considered PV
(not to confound with peak pulmonary artery pressure),
PLA the left atrial pressure at this same time, Q the peak
venous flow through the lobe, and R the hemodynamical
resistance opposed by the lobe to flow Q (without the
contribution of the stenosis). The summand RQ is thus
the pressure drop in the lobe without the contribution of
the stenosis. We have thus:
PPA - PLA = (R + f1 + f3) Q + f2 Q2 (7)
or, equivalently:
f2 Q2+ (R + f1 + f3) Q + (PLA - PPA) = 0 (8)
This quadratic equation allows to determine the value of
Q when the values of f1, f2, f3, R, PLA, and PPA are known.
One can thus calculate the value of Q for different degrees
of diameter stenosis (for instance DS = 1, 5, 10, 15, ..., 90,
95, and 99%). The values of the coefficients f1, f2, and f3
are obtained from equations 1 to 4. They depend on the
blood density and viscosity, and on the morphology of
the stenosis.
The value of R is determined as follows. We consider the
situation preceding the creation of the stenosis (DS = 0%).
Denoting the peak flow through the considered lobe by
Qo, and the corresponding resistance of the lobe by Ro, we
have PPA - PLA = RoQo, so that Ro = (PPA - PLA)/Qo. For Qo,
we can set for instance Qo = 23.6 ml/s (= 1.4 liter/min).
The hemodynamical resistance Ro for DS = 0% being thus
determined, one can then assume for instance that it
remains unchanged when a stenosis appears, or have it
decrease in a freely chosable manner to simulate a lower-
ing of the hemodynamical resistance by compensatory
vasodilatation. Inversely, one can also have Ro increase to
simulate a pathologic, progressive narrowing of the
affected pulmonary vessels by increasing stenosis severity.
C) Calculation of the increase in axial wall stress
To calculate the increase in axial stress generated by the
stenosis in the wall cross section x = 0 at peak flow, one
has to calculate first the supplementary axial force F that is
generated in this cross section. As shown in [27], this is
done using equations 1 to 4. It leads to:
Division of the force F by the cross sectional area of the
wall at x = 0 yields the supplementary axial stress that adds
at peak flow to the "normal" axial stress of the wall.
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